Table 2 Correlation between the CTHRC1 expression and clinical characteristics in EOC
Clinical Characteristics | N | CTHRC1 expression | P value | |
|---|---|---|---|---|
Low | High | |||
Age | 0.083 | |||
< 50 | 25 | 9 | 16 | |
> 50 | 47 | 27 | 20 | |
Histological subtypes | 0.336 | |||
Mucinous | 5 | 4 | 1 | |
Serous | 45 | 21 | 24 | |
Clear cell | 4 | 1 | 3 | |
Endometrioid | 16 | 8 | 8 | |
Others | 2 | 2 | 0 | |
Tumor grade | 0.239 | |||
High | 18 | 7 | 11 | |
Medium | 23 | 10 | 13 | |
Low | 31 | 19 | 12 | |
FIGO stage | 0.018 | |||
I-II | 34 | 22 | 12 | |
III-IV | 38 | 14 | 24 | |
Lymph node metastasis | 0.001 | |||
Yes | 24 | 5 | 19 | |
No | 48 | 31 | 17 | |
Distance metastasis | 0.001 | |||
Yes | 34 | 10 | 24 | |
No | 38 | 26 | 12 | |
Ascites-derived cancer cells | 0.018 | |||
Yes | 34 | 12 | 22 | |
No | 38 | 24 | 14 | |